Company
Pasithea Therapeutics
Pasithea is a biotechnology company focused on the discovery, research and development of innovative treatments for central nervous system (CNS) disorders and RASopathies.
Also known as Pasithera Therapeutics Corp.
- Status
- Operatingas of 2026-09-18Source (opens in a new tab)
- Business model
- B2B
- Legal name
- Pasithera Therapeutics Corp.
- pasithea.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Pasithea is developing new therapeutics for the treatment of neurological disorders, including solid tumors, Neurofibromatosis type 1 (NF1), Amyotrophic Lateral Sclerosis (ALS), and schizophrenia
Funding snapshot
- Total raised
- $31.8MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $30.4M2021-11-29
Funding rounds
- Round, 2021
- $30.4M2021-11-29, SEC form D sold, 21 investors
- Round, 2021
- $1.2M2021-01-03, SEC form D sold, 30 investors
- Round, 2020
- $250K2020-11-24, SEC form D sold, 1 investor
Loading relationship preview